Occidental Petroleum
OXY
$61.78
+0.52%
Occidental Petroleum Corporation is an independent exploration and production company operating across the United States, Latin America, and the Middle East, with net proved reserves of 4.6 billion barrels of oil equivalent and 2025 net production averaging 1.4 million barrels of oil equivalent per day at a roughly 74% oil and NGL / 26% natural gas mix. The company is best understood as a high-beta-on-oil pure-play E&P with an integrated midstream arm, distinguished less by scale than by its outsized oil leverage, its Permian and Gulf of America resource depth, and the persistent strategic backing of Berkshire Hathaway, which has retained its OXY stake even while trimming other energy holdings. The current investor narrative is a balance-sheet repair and capital-returns story: management has prioritized deleveraging following the CrownRock acquisition, and the stock has responded with a 45% year-to-date gain as oil prices firmed on Middle East supply risk. The debate now centers on whether the improved balance sheet and a rare Evercore ISI double-upgrade to Outperform can sustain momentum if crude rolls over, given the company's thin interest coverage and sensitivity to realized prices.…
OXY
Occidental Petroleum
$61.78
Related headlines
Investment Opinion: Should I buy OXY Today?
The synthesized recommendation is Hold. While the analyst consensus is Buy with an average target of $67.12 (9.2% upside), the stock's 45% YTD run has already priced in much of the recovery, and the severe margin compression and negative free cash flow warrant caution. The core thesis is that OXY offers deep value on EV/EBITDA (5.32x) and price-to-book (1.11x), but this value is contingent on oil prices remaining firm and the balance sheet continuing to repair. Supporting evidence includes the forward PE of 15.59x, which implies a 56% earnings recovery, and the recent upgrades from Evercore ISI and Barclays. However, revenue is declining at 23.12% YoY, gross margins have collapsed to 11.85%, and free cash flow is negative at -$298 million, with interest coverage below 1.0x. The dividend yield of 3.97% is attractive but at risk if cash flow does not improve. The biggest risks are a sustained oil price decline, failure to deleverage, and a dividend cut. The rating would upgrade to Buy if oil prices stabilize above $80 and free cash flow turns positive, or downgrade to Sell if revenue declines accelerate or interest coverage remains below 1.0x for multiple quarters. Relative to its own history, the stock is undervalued on PB and PS, but the market is pricing in a recovery that may not materialize, making it fairly valued at best given the risks.
Sign up to view all
OXY 12-Month Price Forecast
OXY presents a high-risk, high-reward opportunity heavily dependent on oil prices. The deep value multiples and analyst upgrades are offset by severe margin compression, negative free cash flow, and interest coverage below 1.0x. The stock's 45% YTD gain has already priced in a recovery, leaving limited upside unless oil prices rise further. I would upgrade to bullish if oil sustains above $80 and free cash flow turns positive, or downgrade to bearish if oil falls below $65 and the dividend is cut. The Berkshire backing provides some downside support, but the company's financial health remains fragile.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Occidental Petroleum's 12-month outlook, with a consensus price target around $67.56 and implied upside of +9.4% versus the current price.
Average Target
$67.56
0 analysts
Implied Upside
+9.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$55 - $79
Analyst target range
Coverage is robust with 25 analysts, and the consensus recommendation is Buy with a recommendation mean of 2.31 (where lower is more bullish), indicating a moderately constructive but not euphoric stance. The average target price of $67.12 implies approximately 9.2% upside from the current $61.46, a modest expected return that reflects how much of the recovery is already priced in after the 45% YTD run. The consensus leans bullish on balance, but the 2.31 mean — closer to Hold than to Strong Buy — suggests a meaningful cohort of analysts see the stock as fairly valued at current levels, consistent with the cluster of Neutral/Equal Weight/Sector Perform ratings from Morgan Stanley, UBS, Scotiabank, Citigroup, and Truist. The target range spans $55.00 to $79.00, a spread of $24 or roughly 39% of the current price, which signals elevated disagreement about the oil-price path and the pace of deleveraging. The high target of $79 implies roughly 28.5% upside and likely assumes sustained higher crude prices, successful debt reduction, and multiple expansion back toward mid-cycle E&P levels; the low target of $55 implies about 10.5% downside and prices in softer oil, continued margin compression, and the risk that interest coverage remains below 1.0x. Institutional rating flow has turned constructive: Evercore ISI's July 2026 double-upgrade from Underperform to Outperform and Barclays' May 2026 upgrade from Equal Weight to Overweight are the most significant positive signals, while the steady stream of reiterations at Neutral/Equal Weight suggests the bulls are gaining ground but have not yet achieved consensus. The wide target spread, combined with the recent upgrades and the stock's 8.9% distance from its 52-week high, argues for treating OXY as a high-conviction-but-high-volatility position where oil-price direction, not analyst sentiment, will ultimately determine the outcome.
Drowning in data?
Find the real signal!
Bulls vs Bears: OXY Investment Factors
The bear case currently has stronger evidence due to the severe margin collapse, negative free cash flow, and interest coverage below 1.0x, which collectively signal financial stress. However, the bull case rests on deep value multiples, analyst upgrades, and Berkshire's backing, which could drive a re-rating if oil prices remain firm. The single most important tension is the direction of oil prices: if crude sustains above $80, OXY's cash flow and margins would recover sharply, validating the bull thesis; if oil rolls over, the company's thin coverage and negative FCF could force asset sales or a dividend cut, triggering a bear case. The stock's high oil beta means its fate is tied to commodity markets rather than company-specific execution, making it a tactical bet on energy prices rather than a stable compounder.
Bullish
- Oil leverage drives outsized upside: OXY is a high-beta-on-oil pure-play with 74% of production in oil and NGLs, and its 45.02% YTD gain has crushed the S&P 500's 12.08% as crude firmed on Middle East supply risk. The stock's 1-month relative strength of +6.03% and YTD relative strength of +32.94% confirm it is currently a market leader, and any sustained oil rally would flow almost directly to revenue and earnings.
- Deep value on multiple metrics: At 5.32x EV/EBITDA, 1.11x price-to-book, and 1.86x price-to-sales, OXY trades near the bottom of its own historical valuation bands (PB range 1.13x-2.13x, PS range 3.48x-12.12x). The forward PE of 15.59x is undemanding for a large-cap E&P and implies the market expects earnings to roughly 56% above the depressed trailing base, a recovery that could materialize if oil holds.
- Analyst consensus sees upside: With 25 analysts covering the stock, the consensus recommendation is Buy (mean 2.31) and the average target price of $67.12 implies 9.2% upside from $61.46. The high target of $79 implies 28.5% upside and recent upgrades from Evercore ISI (double-upgrade to Outperform) and Barclays (to Overweight) suggest institutional sentiment is turning more constructive.
- Berkshire backing provides stability: Berkshire Hathaway has retained its OXY stake even while trimming other energy holdings, and recent news highlights that Greg Abel has not touched Berkshire's energy holdings. This strategic backing provides a valuation floor and signals long-term confidence in OXY's asset base and management strategy.
Bearish
- Revenue and margins collapsing: Q1 2026 revenue fell 23.12% YoY to $5.23 billion, and gross margin collapsed to 11.85% from 36.09% a year earlier and 27.81% in Q4 2025. This severe realized-price compression and rising unit costs directly threaten earnings and cash flow, and the 67.3% payout ratio leaves little cushion if the downturn persists.
- Interest coverage below 1.0x: Q1 2026 EBIT of $375 million did not cover interest expense of $432 million, resulting in an interest coverage ratio of 0.868. With a current ratio of 0.936 (current liabilities exceed current assets) and negative quarterly free cash flow of -$298 million, the company is dependent on asset sales and financing to fund dividends and capex.
- Negative free cash flow and high payout: Free cash flow turned negative at -$298 million in Q1 2026 versus +$1.881 billion in Q4 2025, driven by $1.579 billion of capex against only $1.281 billion of operating cash flow. The dividend consumes $409 million per quarter, and with negative FCF, the payout ratio of 67.3% is unsustainable without asset sales or higher oil prices.
- Valuation distorted by depressed earnings: The trailing PE of 24.33x is inflated by trailing EPS of just $0.059, and the negative PEG ratio of -0.70 and negative price-to-free-cash-flow ratio of -212.8 signal that trailing cash earnings cannot support the multiple. The market is pricing in a sharp earnings recovery that may not materialize if oil prices weaken.
OXY Technical Analysis
OXY is in a sustained recovery uptrend, with the shares up 33.55% over the past year and 45.02% year-to-date, decisively outperforming the S&P 500's 16.22% and 12.08% respective gains. At $61.46, the stock sits at roughly 80.6% of its 52-week range (52-week low of $38.80, high of $67.45), a positioning that reflects genuine momentum but also leaves limited headroom before overhead resistance. The 27.63% maximum drawdown over the trailing period confirms this has been a volatile climb rather than a smooth trend, and the fact that price is still 8.9% below the 52-week high suggests the market has not yet fully re-rated the equity to its prior peak. Short-term momentum is constructive but decelerating: the 1-month gain of 4.97% and 3-month gain of 8.70% are both positive, yet the 6-month change of just 6.19% implies most of the move occurred in the first half of the year, with a summer consolidation phase in between. Relative strength versus SPY is strongly positive across every window except the 6-month (-9.21%), a divergence that signals OXY's outperformance is recent and accelerating rather than a stale, mature trend — the 1-month relative strength of +6.03% and YTD relative strength of +32.94% confirm the stock is currently a market leader. Key technical support sits at the 52-week low of $38.80, with a more immediate psychological floor near the $50 area where the June-July basing occurred; resistance is defined by the 52-week high of $67.45, and a clean breakout above that level would likely trigger momentum-fund accumulation and open a path toward the analyst high target of $79. A breakdown below $50 would negate the recovery thesis and refocus the market on the 52-week low. Notably, the reported beta of 0.164 is anomalously low for an E&P name and likely reflects a data artifact or a measurement window dominated by idiosyncratic moves; investors should treat OXY's true market sensitivity as materially higher given its oil-price linkage, and size positions accordingly.
Beta
0.16
0.16x market volatility
Max Drawdown
-27.6%
Largest decline past year
52-Week Range
$39-$67
Price range past year
Annual Return
+35.3%
Cumulative gain past year
| Period | OXY Return | S&P 500 |
|---|---|---|
| 1m | +5.9% | -2.0% |
| 3m | +15.1% | +1.4% |
| 6m | +5.8% | +15.0% |
| 1y | +35.3% | +15.7% |
| ytd | +45.8% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OXY Fundamental Analysis
Revenue is contracting sharply on a year-over-year basis, with Q1 2026 revenue of $5.23 billion representing a 23.12% decline from the prior-year quarter's $6.80 billion. The multi-quarter trend is one of sequential erosion: revenue fell from $6.80 billion in Q1 2025 to $6.32 billion in Q2, $6.62 billion in Q3, $5.01 billion in Q4, and $5.23 billion in Q1 2026, a pattern driven by lower realized commodity prices rather than volume loss. Segment data shows the Oil and Gas segment generating $10.21 billion against just $612 million from Midstream, underscoring that the investment case is almost entirely a directional bet on upstream hydrocarbon realizations. The growth trajectory is therefore not a company-execution story but a commodity-price story, and the 23% revenue decline explains why trailing EPS of just $0.059 looks so depressed relative to the $4.86 consensus forward EPS estimate. Profitability is positive but volatile and thin at the GAAP level: Q1 2026 net income of $3.345 billion was inflated by a large non-cash item (the quarter included a $9.395 billion other-investing inflow and a $6.903 billion debt repayment, suggesting asset-sale gains), while the reported gross margin of 11.85% is far below the 33.78% trailing figure and the 27.8%-36.1% range seen through 2025. The Q1 2026 gross margin collapse to 11.85% from 27.81% in Q4 2025 and 36.09% in Q1 2025 is the single most important fundamental datapoint — it signals severe realized-price compression and rising unit costs. Net margin of 10.97% and operating margin of 17.24% remain respectable for the sector but are well off the 24.6% operating margins OXY posted in 2024, and the 67.3% payout ratio leaves little cushion if earnings deteriorate further. Balance sheet health is the crux of the story: debt-to-equity of 0.665 is moderate, but the current ratio of 0.936 means current liabilities exceed current assets, and the Q1 2026 interest coverage ratio of 0.868 (EBIT of $375 million against $432 million of interest expense) indicates operating earnings did not cover interest in the quarter. Free cash flow turned negative at -$298 million in Q1 2026 versus +$1.881 billion in Q4 2025 and +$3.567 billion TTM, a swing driven by $1.579 billion of capex against only $1.281 billion of operating cash flow. ROE of 6.57% and ROA of 4.68% are modest, and with the dividend consuming $409 million per quarter against negative quarterly FCF, the company is currently dependent on asset sales and financing to fund returns — a genuine risk if oil weakens.
Quarterly Revenue
$5.2B
2026-03
Revenue YoY Growth
-23.1%
YoY Comparison
Gross Margin
11.8%
Latest Quarter
Free Cash Flow
$3.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OXY Overvalued?
Because OXY is profitable on a trailing basis (net income positive, EPS of $0.059), the PE ratio is the appropriate primary metric, though the trailing PE of 24.33x is distorted by the depressed trailing earnings base and is far less informative than the forward PE of 15.59x. The gap between trailing (24.33x) and forward (15.59x) PE implies the market expects earnings to roughly 56% higher over the next twelve months, consistent with the $4.86 consensus forward EPS versus the near-zero trailing figure — a recovery that depends almost entirely on higher realized oil prices. On EV/EBITDA of 5.32x and EV/Sales of 3.37x, the stock looks reasonably valued for a large-cap E&P, and the price-to-book of 1.11x is undemanding. Peer comparison is constrained by the absence of an explicit industry-average multiple in the provided data, but contextually, large-cap E&Ps typically trade in the 6x-9x EV/EBITDA band, suggesting OXY at 5.32x is trading at a discount to the sector — a discount that is arguably justified by its below-investment-grade-adjacent leverage profile, negative quarterly free cash flow, and interest coverage below 1.0x. The 1.11x price-to-book versus the sector's typical 1.5x-2.0x range reinforces the value framing, but value here is contingent on balance-sheet repair continuing. Historically, OXY's own valuation band has compressed dramatically: the PE ratio ranged from 2.86x (Q1 2022) to 38.9x (Q2 2025) and the PS ratio from 3.48x (Q4 2021) to 12.12x (Q1 2026), with the current PS of 1.86x sitting at the very bottom of that multi-year range. The current PB of 1.11x is likewise near the low end of its historical 1.13x-2.13x band, and the EV/EBITDA of 5.32x compares favorably to the 11x-33x range seen over the past four years. This places OXY near the bottom of its own historical valuation band, which can be read either as a genuine value opportunity if oil holds or as the market pricing in structural earnings deterioration — the negative PEG ratio of -0.70 and negative price-to-free-cash-flow ratio of -212.8 both signal that trailing cash earnings cannot currently support the multiple.
PE
24.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 3x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
5.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are acute: Q1 2026 revenue declined 23.12% YoY to $5.23 billion, and gross margin collapsed to 11.85% from 36.09% a year earlier, reflecting severe realized-price compression. Interest coverage fell below 1.0x (EBIT of $375 million vs. interest expense of $432 million), and free cash flow turned negative at -$298 million, while the dividend consumes $409 million per quarter. With a current ratio of 0.936 and debt-to-equity of 0.665, the company has limited liquidity cushion and is reliant on asset sales or financing to fund returns, posing a risk of dividend cuts or further balance-sheet deterioration if oil prices weaken. Market and competitive risks include valuation compression if oil prices fall, given the stock's high oil beta (though reported beta of 0.164 is anomalously low and likely a data artifact). The wide analyst target spread ($55-$79) and the 27.63% maximum drawdown highlight elevated volatility, and the stock's 45% YTD gain leaves it vulnerable to profit-taking. Regulatory and geopolitical risks, such as Middle East tensions easing, could remove the supply-risk premium that has supported oil prices, while sector rotation away from energy could pressure the multiple. The worst-case scenario would be a sharp oil price decline (e.g., below $60 per barrel) that exacerbates margin compression, pushes interest coverage further below 1.0x, and forces asset sales or a dividend cut. In this scenario, the stock could retest its 52-week low of $38.80, representing a 36.9% decline from the current price of $61.46, and the analyst low target of $55 implies a 10.5% downside. A more severe downturn could see the stock fall to the low $40s, a loss of roughly 30-35% from current levels.
FAQ
The key risks include: 1) Financial risk: interest coverage below 1.0x (EBIT of $375 million vs. interest expense of $432 million) and negative free cash flow of -$298 million, which could force a dividend cut or asset sales. 2) Commodity price risk: revenue is highly sensitive to oil prices, and a decline below $60 per barrel would severely impact margins and cash flow. 3) Operational risk: gross margin collapsed to 11.85% in Q1 2026 from 36.09% a year earlier, indicating rising unit costs and realized-price compression. 4) Market risk: the stock has a high beta to oil and has experienced a 27.63% maximum drawdown, making it volatile. These risks are ranked from most to least severe, with financial and commodity risks being the most immediate.
The 12-month forecast is based on three scenarios: bull case (25% probability) with a target range of $79-$85, driven by oil prices above $90 and successful deleveraging; base case (50% probability) with a target range of $65-$72, assuming oil averages $75 and gradual balance sheet repair; and bear case (25% probability) with a target range of $45-$55, if oil falls below $60 and the dividend is cut. The base case is most likely, with the key assumption that oil prices remain range-bound and the company maintains its dividend. The analyst average target of $67.12 aligns with the base case, implying 9.2% upside from the current price.
OXY appears undervalued on several metrics relative to its own history and the broader sector. Its EV/EBITDA of 5.32x is below the typical 6x-9x range for large-cap E&Ps, and its price-to-book of 1.11x is near the low end of its historical 1.13x-2.13x band. The price-to-sales of 1.86x is also at the bottom of its multi-year range (3.48x-12.12x). However, the forward PE of 15.59x implies the market expects a 56% earnings recovery, which may not materialize if oil prices weaken. The negative PEG ratio and negative price-to-free-cash-flow ratio highlight that trailing earnings do not support the multiple. Overall, the stock is undervalued relative to its history but fairly valued given the operational risks.
OXY is a good buy only for investors with a high risk tolerance and a bullish outlook on oil prices. The stock trades at a deep value multiple (EV/EBITDA of 5.32x) and has 9.2% upside to the analyst average target of $67.12, but it also carries significant risks: revenue is declining 23.12% YoY, gross margins have collapsed to 11.85%, and free cash flow is negative. The dividend yield of 3.97% is attractive but may be unsustainable if oil prices fall. The recent upgrades from Evercore ISI and Barclays are positive, but the stock has already rallied 45% YTD, so much of the good news may be priced in. For long-term investors, OXY could be a value play if oil prices remain firm, but it is not a low-risk investment.
OXY is more suitable for short-term tactical trading than long-term holding due to its high oil price sensitivity, volatile earnings, and financial fragility. The stock's beta to oil is high (though reported beta of 0.164 is likely a data artifact), and its 27.63% maximum drawdown illustrates the risks. The dividend yield of 3.97% is attractive but at risk if cash flow does not improve. For long-term investors, OXY could be a value play if oil prices remain firm and the balance sheet is repaired, but the lack of earnings visibility and the potential for a dividend cut make it less suitable for conservative portfolios. A suggested minimum holding period is 1-2 years, but only with a bullish oil view and a tolerance for volatility.
